Correlation Between LQwD FinTech and Cardiol Therapeutics
Can any of the company-specific risk be diversified away by investing in both LQwD FinTech and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LQwD FinTech and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LQwD FinTech Corp and Cardiol Therapeutics Class, you can compare the effects of market volatilities on LQwD FinTech and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LQwD FinTech with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of LQwD FinTech and Cardiol Therapeutics.
Diversification Opportunities for LQwD FinTech and Cardiol Therapeutics
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between LQwD and Cardiol is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding LQwD FinTech Corp and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and LQwD FinTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LQwD FinTech Corp are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of LQwD FinTech i.e., LQwD FinTech and Cardiol Therapeutics go up and down completely randomly.
Pair Corralation between LQwD FinTech and Cardiol Therapeutics
Assuming the 90 days trading horizon LQwD FinTech Corp is expected to generate 1.34 times more return on investment than Cardiol Therapeutics. However, LQwD FinTech is 1.34 times more volatile than Cardiol Therapeutics Class. It trades about 0.06 of its potential returns per unit of risk. Cardiol Therapeutics Class is currently generating about 0.06 per unit of risk. If you would invest 54.00 in LQwD FinTech Corp on September 3, 2024 and sell it today you would earn a total of 96.00 from holding LQwD FinTech Corp or generate 177.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
LQwD FinTech Corp vs. Cardiol Therapeutics Class
Performance |
| Timeline |
| LQwD FinTech Corp |
| Cardiol Therapeutics |
LQwD FinTech and Cardiol Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with LQwD FinTech and Cardiol Therapeutics
The main advantage of trading using opposite LQwD FinTech and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LQwD FinTech position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.The idea behind LQwD FinTech Corp and Cardiol Therapeutics Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Cardiol Therapeutics vs. Medipharm Labs Corp | Cardiol Therapeutics vs. Avicanna | Cardiol Therapeutics vs. Medicenna Therapeutics Corp | Cardiol Therapeutics vs. Charlottes Web Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stocks Directory Find actively traded stocks across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |